Will I lose my whole kidney if I have kidney cancer surgery?

Not necessarily. For tumours smaller than 4–7 cm, a partial nephrectomy — removing only the tumour and preserving the rest of the kidney — is often possible and is the preferred option to protect long-term kidney function. Mr Ameen performs robotic partial nephrectomy for eligible tumours, achieving cancer control rates equivalent to total removal.

What happens if my kidney tumour turns out to be benign after surgery?

Approximately 20–25% of kidney tumours removed surgically turn out to be benign on pathological analysis — most commonly oncocytomas or angiomyolipomas. Surgery was still the right decision based on imaging characteristics. In selected cases, a biopsy before surgery may help avoid unnecessary operations.

Robotic Surgery · Kidney Cancer

Robotic Kidney
Cancer Surgery

Q: Will I need chemotherapy after kidney cancer surgery?

Kidney cancer does not respond well to conventional chemotherapy or radiotherapy. For localised disease removed surgically, no additional systemic treatment is needed. For higher-risk disease, adjuvant immunotherapy (pembrolizumab) is now NICE-approved in the UK.

Q: Can I live normally with one kidney?

Yes. Most people live full, healthy lives with a single kidney. The remaining kidney typically recovers to 70–75% of combined function. You will be advised to stay well hydrated, avoid NSAIDs long-term and have kidney function checked annually. Life expectancy is not significantly reduced.

Minimally invasive robotic radical and benign nephrectomy — expert kidney surgery through small keyhole incisions, with most patients home within 1–2 days.

Book a Consultation Call 0204 558 6750

1–2

Nights Typical Hospital Stay

<2%

Major Complication Rate (Robotic)

4–6 wks

Return to Full Activity

95%+

5-Year Survival for Localised Disease

The Procedure

Robotic Radical & Benign Nephrectomy

Radical nephrectomy removes the entire kidney and is the treatment of choice for larger or complex renal tumours, centrally positioned cancers, and cases where complete removal is required to achieve clear oncological margins. It is also performed robotically, providing the same keyhole approach and rapid recovery.

Benign nephrectomy is the removal of a kidney for non-cancerous conditions — including chronic infection, obstruction causing a non-functioning kidney, severe pain, or other structural problems. These cases are managed with the same minimally invasive robotic technique.

Both operations are performed robotically through small port incisions, reducing blood loss, hospital stay and recovery time significantly compared to open surgery.

Every kidney case is different. My focus is on achieving the best oncological outcome — complete cancer control — whilst using the least invasive approach possible. Robotic surgery allows me to do this with greater precision, less blood loss and a faster recovery than open techniques.

— Mr Torath Ameen, FRCS (Urol)

Advantages of Robotic Surgery

Why Choose Robotic Nephrectomy?

Precision Tumour Removal

3D magnification and robotic instrument control allows precise tumour excision with clear margins, even in anatomically complex locations near the renal hilum.

Shorter Hospital Stay

Most patients are discharged 1–2 days after surgery versus 5–7 days for open nephrectomy.

Less Blood Loss

Robotic surgery is associated with significantly lower intraoperative blood loss and a far lower transfusion rate than open surgery.

Faster Recovery

Most patients return to normal activity within 4–6 weeks — compared to 6–12 weeks for open surgery.

Robotic Precision

The da Vinci robotic system provides magnified 3D vision and wristed instruments, enabling precise dissection and significantly reduced blood loss compared with open surgery.

Common Questions

Kidney Cancer Surgery FAQs

What is the difference between radical and benign nephrectomy?

This depends on the size, position and complexity of your tumour, as well as the function of both kidneys. Mr Ameen uses CT or MRI imaging and sometimes a nuclear medicine (DMSA) scan to assess each kidney's contribution to your overall kidney function. He will present both options to you at consultation and make a clear recommendation based on your individual anatomy and cancer characteristics.

What happens if my tumour is found to be benign after surgery?

Approximately 20–25% of kidney tumours removed surgically turn out to be benign (non-cancerous) on pathological analysis — most commonly oncocytomas or angiomyolipomas. While this is reassuring, surgery was still the right decision at the time based on the imaging characteristics. In selected cases, a biopsy before surgery may help avoid unnecessary operations, and Mr Ameen can discuss whether this applies to your situation.

Will I need chemotherapy or radiotherapy after kidney cancer surgery?

Unlike many other cancers, kidney cancer does not respond well to conventional chemotherapy or radiotherapy. For localised disease successfully removed surgically, no additional systemic treatment is needed. For higher-risk disease, adjuvant immunotherapy (pembrolizumab) is now NICE-approved in the UK. Mr Ameen works closely with oncology colleagues to coordinate this if required.

Can I live normally with one kidney?

Yes. Most people live full, healthy lives with a single kidney. The remaining kidney compensates over time, typically recovering to 70–75% of the combined function. You'll be advised to stay well hydrated, avoid NSAIDs (ibuprofen) long-term and have your kidney function checked annually. Life expectancy is not significantly reduced for people who lose one kidney from trauma or surgery.

Concerned about a kidney mass? Get expert advice.

Early assessment gives the best chance of kidney-preserving surgery. Mr Ameen offers rapid private consultations across Central London.

Book Online Now Call 0204 558 6750

Robotic KidneyCancer Surgery